Immune checkpoint inhibitors can significantly improve cancer survival rates. But resulting immune-related toxicities are common, requiring multidisciplinary cooperation between oncology and neurology.
This episode, PN's podcast editor Dr. Amy Ross Russell speaks with a panel of experts on the balancing act required when treating cancer patients with these ... Show More
Jul 25
Papilloedema, Parkinson's follow-up, and subhairline EEG - Editors' Highlights August 2026
The latest highlights from the journal will deliver confidence when managing complex everyday presentations. In this podcast for the August 2026 issue of Practical Neurology, co-editors Phil Smith and Geraint Fuller present the key highlights from a cracking 100-page edition span ... Show More
46m 14s
Sep 2020
Immunotherapy: Transforming How Cancers Are Treated
In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ... Show More
23m 44s
Sep 2024
Episode 200: Immune Checkpoint Inhibitors
We discuss a new class of medications, Immune Checkpoint Inhibitors, and their side effects. Hosts: Avir Mitra, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Immune_Checkpoint_Inhibitors.mp3 Download Leave a Comment Tags: Oncology Show Notes Ov ... Show More
13m 26s
Oct 2024
152| Cancer Therapies and Brain Health – A Conversation with Dr. Mike Parsons and Dr. Jorg Dietrich
<p>In this episode on systemic, non-CNS cancer therapies and brain health, with Drs. Michael Parsons and Jorg Dietrich, we discuss basic concepts in cancer biology, the impact of cancer therapies on cognition, mechanisms by which non-CNS treatments impact brain health, the role o ... Show More
1h 48m
Oct 2025
Ep. 245 Understanding Keynote-689: Immunotherapy for Head & Neck Cancer with Dr. Dylan Roden, Dr. Ravi Uppaluri and Dr. Adam Luginbuhl
While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using perioperative pembrolizumab is forcing clinicians to rethink their entire workflow, starting with diagnosis. In this episode of the BackTable Podcast, head and neck surgica ... Show More
40m 45s
Jun 2022
#342 Checkpoint Inhibitors: The power, and adverse effects, of immunotherapy (ACP 2022)
With great power comes great immunogenicity. Learn about the ins and outs of immunotherapy–its indications, its power, and its adverse effects–in this episode with Dr. Christian Cable, hematologist/oncologist and medical educator extraordinaire. We learn a riveting history of imm ... Show More
54m 36s